Pages that link to "Q46882515"
Jump to navigation
Jump to search
The following pages link to Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression (Q46882515):
Displaying 50 items.
- STAT3 protein up-regulates Gα-interacting vesicle-associated protein (GIV)/Girdin expression, and GIV enhances STAT3 activation in a positive feedback loop during wound healing and tumor invasion/metastasis (Q24300906) (← links)
- HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis (Q24598092) (← links)
- SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells (Q24656966) (← links)
- STATs: An Old Story, Yet Mesmerizing (Q26783285) (← links)
- Targeting SH2 domains in breast cancer (Q27014674) (← links)
- Developmental therapeutics for inflammatory breast cancer: Biology and translational directions (Q28075322) (← links)
- 2,2'-diphenyl-3,3'-diindolylmethane: a potent compound induces apoptosis in breast cancer cells by inhibiting EGFR pathway (Q28489107) (← links)
- Amplification of HER2 is a marker for global genomic instability (Q33375856) (← links)
- MS-1020 is a novel small molecule that selectively inhibits JAK3 activity (Q33507716) (← links)
- Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway (Q33575279) (← links)
- Initiation factor eIF2-independent mode of c-Src mRNA translation occurs via an internal ribosome entry site (Q33648488) (← links)
- Identification of a Stat3-dependent transcription regulatory network involved in metastatic progression. (Q33740488) (← links)
- Expression of RUNX1 correlates with poor patient prognosis in triple negative breast cancer (Q33812500) (← links)
- CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells (Q33874823) (← links)
- Far beyond the usual biomarkers in breast cancer: a review (Q33935217) (← links)
- Coordination complex SH2 domain proteomimetics: an alternative approach to disrupting oncogenic protein-protein interactions (Q34022050) (← links)
- The oncogenic potential of human cytomegalovirus and breast cancer (Q34081724) (← links)
- Stat3 mediates expression of autotaxin in breast cancer (Q34091068) (← links)
- Curcumin: a potential candidate in prevention of cancer via modulation of molecular pathways (Q34252516) (← links)
- Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells (Q34253370) (← links)
- Signal transducer and activators of transcription 3 regulates cryptotanshinone-induced apoptosis in human mucoepidermoid carcinoma cells (Q34304566) (← links)
- The role of inflammation in inflammatory breast cancer. (Q34419629) (← links)
- Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression (Q34483555) (← links)
- Cucurbitacin B inhibits proliferation and induces apoptosis via STAT3 pathway inhibition in A549 lung cancer cells (Q34487928) (← links)
- Molecular mechanisms of action and potential biomarkers of growth inhibition of dasatinib (BMS-354825) on hepatocellular carcinoma cells (Q34747847) (← links)
- Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation (Q34989115) (← links)
- Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer models (Q35013694) (← links)
- Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells (Q35013758) (← links)
- Gambogic acid inhibits STAT3 phosphorylation through activation of protein tyrosine phosphatase SHP-1: potential role in proliferation and apoptosis (Q35091267) (← links)
- Signal transducer and activator of transcription-3 and breast cancer prognosis. (Q35112311) (← links)
- Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030. (Q35125616) (← links)
- Increased STAT1 signaling in endocrine-resistant breast cancer (Q35146693) (← links)
- Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases (Q35224775) (← links)
- STAT3 and STAT5b polymorphism contributes to breast cancer risk and clinical outcomes (Q35405293) (← links)
- Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator (Q35604324) (← links)
- The Status of STAT3 and STAT5 in Human Breast Atypical Ductal Hyperplasia (Q35683077) (← links)
- Constitutive activation of JAK2 in mammary epithelium elevates Stat5 signalling, promotes alveologenesis and resistance to cell death, and contributes to tumourigenesis (Q35737909) (← links)
- Persistent activation of STAT3 by PIM2-driven positive feedback loop for epithelial-mesenchymal transition in breast cancer (Q35754295) (← links)
- Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells through STAT3 activation (Q35793771) (← links)
- Salinomycin Promotes Anoikis and Decreases the CD44+/CD24- Stem-Like Population via Inhibition of STAT3 Activation in MDA-MB-231 Cells (Q35830305) (← links)
- Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis (Q35840236) (← links)
- Constitutively activated Stat3 induces tumorigenesis and enhances cell motility of prostate epithelial cells through integrin beta 6 (Q35857048) (← links)
- Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer. (Q35906313) (← links)
- Targeting the interleukin-6/Jak/stat pathway in human malignancies (Q35925127) (← links)
- A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development. (Q36029588) (← links)
- Role of STAT3 in lung cancer (Q36086059) (← links)
- Immunohistochemical analysis of phosphotyrosine signal transducer and activator of transcription 3 and epidermal growth factor receptor autocrine signaling pathways in head and neck cancers and metastatic lymph nodes. (Q36180104) (← links)
- TCPTP regulates SFK and STAT3 signaling and is lost in triple-negative breast cancers. (Q36560020) (← links)
- The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibition (Q36583525) (← links)
- Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity (Q36612010) (← links)